Effective replacement therapy for some clotting disorders

Prescrire International

Volumn 12, Issue 63, 2003, Pages 11-13

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; FRESH FROZEN PLASMA; PROTEIN C; PROTEXEL;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD DONOR; CASE STUDY; CHILD; CLINICAL PRACTICE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MARKETING; EUROPE; HUMAN; HYPERVOLEMIA; INFECTION RISK; MEDICAL DOCUMENTATION; PROPHYLAXIS; PROTEIN C DEFICIENCY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKIN NECROSIS; STROKE; VEIN THROMBOSIS;

EID: 0037601933     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Ehrlich H "Expert report on the clinical documentation of Ceprotin°" undated: 50 pages.
2. The European Agency for the Evaluation of Medicinal Products - Committee for Proprietary Medicinal Products - European Public Assessment Report" Ceprotin°" London 2001; 67 pages.
3. Dreyfus M et al. "Inherited protein C deficiency: efficacy and safety study of Protexel°" XXVth Congress of WFH, May 2002, Seville: 1 page.
4. "Protexel°. In French datasheet compendium: "Dictionnaire Vidal - mises à jour cumulatives janvier/mai 2002" Vidal, Paris 2002: 95-96.